tiprankstipranks
Trending News
More News >
Zealand Pharma (DE:22Z)
FRANKFURT:22Z
Germany Market

Zealand Pharma (22Z) Technical Analysis

Compare
10 Followers

Summary of all the Indicators

Overall Consensus
Sell
5Bullish
2Neutral
15Bearish
Technical Analysis Consensus
Buy
5Bullish
2Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Zealand Pharma’s (22Z) Moving Averages Convergence Divergence (MACD) indicator is -2.27, suggesting Zealand Pharma is a Buy.
Zealand Pharma’s (22Z) 20-Day exponential moving average is 57.30, while Zealand Pharma’s (22Z) share price is €49.76, making it a Sell.
Zealand Pharma’s (22Z) 50-Day exponential moving average is 61.02, while Zealand Pharma’s (22Z) share price is €49.76, making it a Sell.

Zealand Pharma (22Z) Pivot Points

Jun 27, 2025, 04:31 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
49.92
50.68
51.06
51.82
52.20
52.96
53.34
Fibonacci
50.68
51.12
51.38
51.82
52.26
52.52
52.96
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Zealand Pharma (22Z) Moving Averages

Jun 27, 2025, 04:31 AM
Period
Simple
Exponential
MA5
51.15Sell
52.12Sell
MA10
57.11Sell
54.99Sell
MA20
59.53Sell
57.30Sell
MA50
58.61Sell
61.02Sell
MA100
70.51Sell
69.39Sell
MA200
87.61Sell
85.15Sell
Zealand Pharma’s (22Z) 10-Day exponential moving average is 54.99, while Zealand Pharma’s (22Z) share price is €49.76, making it a Sell.
Zealand Pharma’s (22Z) 100-Day exponential moving average is 69.39, while Zealand Pharma’s (22Z) share price is €49.76, making it a Sell.
Zealand Pharma’s (22Z) stock price is €49.76 and Zealand Pharma’s (22Z) 50-day simple moving average is 58.61, creating a Sell signal.
Zealand Pharma’s (22Z) stock price is €49.76 and Zealand Pharma’s (22Z) 100-day simple moving average is 70.51, creating a Sell signal.
Zealand Pharma’s (22Z) stock price is €49.76 and Zealand Pharma’s (22Z) 200-day simple moving average is 87.61, creating a Sell signal.

Zealand Pharma (22Z) Technical Indicators

Jun 27, 2025, 04:31 AM
Name
Value
Implied Action
RSI (14)
32.59
Neutral
STOCH (9,6)
6.32
Buy
STOCHRSI (14)
6.32
Buy
MACD (12,26)
-2.27
Buy
ADX (14)
21.99
Neutral
Williams %R
-100.00
Buy
CCI (14)
-166.61
Buy
ATR (14)
2.31
-
Ultimate Oscillator
24.02
Sell
ROC
-18.54
Sell
Zealand Pharma’s (22Z) Relative Strength Index (RSI) is 32.59, creating a Neutral signal.
Zealand Pharma’s (22Z) Trend Strength Indicator (ADX) is 21.99, creating a Neutral signal.
Zealand Pharma’s (22Z) Commodity Channel Index (CCI) is -166.61, creating a Buy signal.
Zealand Pharma’s (22Z) Price Rate of Change (ROC) is -18.54, creating a Sell signal.

FAQ

Is 22Z a Buy, Hold, or Sell?
Based on 22Z’s technical indicators, 22Z is a Sell.
    What is 22Z’s RSI (14)?
    22Z’s RSI (14) is 32.59, which suggests 22Z is a Neutral.
      What is 22Z’s MACD?
      22Z’s MACD is -2.27, which suggests 22Z is a Buy.
        What is 22Z’s 5-day moving average?
        22Z’s 5-day moving average is 51.15, which suggests 22Z is a Sell.
          What is 22Z’s 20-day moving average?
          22Z 20-day moving average is 59.53, which suggests 22Z is a Sell.
            What is 22Z’s 50-day moving average?
            22Z’s 50-day moving average is 58.61, which suggests 22Z is a Sell.
              What is 22Z’s 200-day moving average?
              22Z’s 200-day moving average is 87.61, which suggests 22Z is a Sell.
                What is 22Z’s Williams % R (14)?
                22Z’s Williams % R (14) is -100.00, which suggests 22Z is a Buy.
                  What is 22Z’s CCI (14)?
                  22Z’s CCI (14) is -166.61, which suggests 22Z is a Buy.
                    What is the share price of Zealand Pharma?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis